palmitoyl sh-oligopeptide-79은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

palmitoyl sh-oligopeptide-79은 임신 중 안전한가요?

No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment listing reproductive hazard, and no peer‑reviewed data indicating teratogenicity or reproductive toxicity for this ingredient name. Palmitoyl‑conjugated cosmetic peptides generally have high molecular weight and low dermal absorption, supporting negligible exposure from topical use (sources: ECHA Annex VI, SCCS/CIR absence, PubMed/CosIng absence of adverse findings).

palmitoyl sh-oligopeptide-79은 모유 수유 중 안전한가요?

No evidence of reproductive or lactation-related hazard in regulatory databases or peer‑reviewed literature; topical peptides of this type are not reported to have systemic reproductive/mammary effects and are expected to have negligible systemic availability after dermal application (sources: absence in SCCS/CIR, PubMed, CosIng).

palmitoyl sh-oligopeptide-79은 아기 피부에 안전한가요?

No infant-specific toxicity data found and no regulatory classification for reproductive/developmental hazard. Mechanistic concerns are absent. Dermal absorption for palmitoyl peptides is generally low in adults, but because infant skin has higher surface‑area‑to‑weight and immature barrier, exposure score is increased to 1 (low but measurable) relative to adults (sources: CosIng/PubChem absence of hazard data; general dermal absorption principles).

VeriMom은 palmitoyl sh-oligopeptide-79을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 palmitoyl sh-oligopeptide-79을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 palmitoyl sh-oligopeptide-79 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.